News
The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said ...
Conflicts of interest on federal government vaccine panels have declined to “historically low levels” in recent years ...
The MFN executive order introduces uncertainty in pharma pricing strategies, necessitating careful risk assessment and ...
The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...
A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...
8d
OpenSecrets on MSNPharma industry and Ballard Partners dominate the lobbying space in second quarter of 2025
OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...
6h
TipRanks on MSNCinclus Pharma Reports H1 2025 Financial Results Amid Ongoing Challenges
The latest update is out from Cinclus Pharma Holding AB ( (SE:CINPHA) ).
OPINION: The pharmaceutical industry has one of the lowest approval ratings of any industry in the country. A recent poll found that just 31% of Americans trust the pharmaceutical industry, and 78 ...
Get the latest news, photos, videos, and more on Pharmaceutical industry from Yahoo - Latest News & Headlines.
The pharmaceutical industry stands at a critical juncture. To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered technologies is ...
Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...
The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results